Skip to main content

NINE MASTS CAPITAL Ltd

Position in SGMOQ — Sangamo Therapeutics, Inc

CIK 1569356 CENTRAL, K3

Position in SGMOQ

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$28,366
New position
Shares Held
113,465
first reported quarter
Ownership
0.027%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NINE MASTS CAPITAL Ltd holds $2,069,717 across 4 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in SGMOQ

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $28,366 113,465